A panel of intestinal differentiation markers (CDX2, GPA33, and LI-cadherin) identifies gastric cancer patients with favourable prognosis
Nair Lopes, Christian H. Bergsland, Jarle Bruun, Merete Bjørnslett, André Filipe Vieira, Patrícia Mesquita, Rita Pinto, Rosa Gomes, Bruno Cavadas, Eric Bennett, Luı́sa Pereira, Ragnhild A. Lothe, Raquel Almeida, Leonor David
Topics & Concepts
CDX2CancerSurgical oncologyMedicineTissue microarrayImmunohistochemistryCadherinPathologyInternal medicineCancer researchOncologyBiologyGene expressionGeneGeneticsCellHomeoboxDigestive system and related healthCancer Cells and MetastasisHelicobacter pylori-related gastroenterology studies